Policomponent Phytotherapy in Treatment in Diseases of Рrostatae

##plugins.themes.bootstrap3.article.main##

І. І. Горпинченко
Ю. М. Гурженко
В. В. Спиридоненко

Abstract

The article presents the theoretical foundations to help the practitioner to optimize the treatment of cases of prostatic inflammation disease using a combination of extracts of goldenrod ordinary, common aspen leaf, powder pumpkin seeds and pumpkin globulin.

##plugins.themes.bootstrap3.article.details##

How to Cite
Горпинченко, І. І., Гурженко, Ю. М., & Спиридоненко, В. В. (2019). Policomponent Phytotherapy in Treatment in Diseases of Рrostatae. Health of Man, (1), 27–30. https://doi.org/10.30841/2307-5090.1.2019.172508
Section
Topical issues

References

Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015 Oct;22(5 Suppl 1):1-6.

Sciarra A., Di Silverio F., Salciccia S. et al. 2007 Inflammation and Chronic Prostatic Diseases: Evidence for a Link? Eur. Urol.: 52. 964-972.

Горпинченко .І., Гурженко Ю.М., Спиридоненко В.В. Сучасні дані про вплив хронічного запалення в патогенезі доброякісної гіперплазії передміхурової залози і раку передміхурової залози // Здоровье мужчины. – 2014. – № 4. – С. 91–94.

Coulson S, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L. A phase II randomised double blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. Complement Ther Med. 2013 Jun;21(3):172-9.

Bains SN, Hamilton RG, Abouhassan S, Lang D, Han Y, Hsieh FH. Identification of clinically relevant cross-sensitization between Soliadgo virgaurea (goldenrod) and Hevea brasiliensis (natural rubber latex). J Investig Allergol Clin Immunol. 2010;20(4):331-9.

Back CG, Nam GY, Lee SY, Jung HY. Outbreak of Rust Caused by Coleosporium asterum on Solidago virgaurea var. gigantea in Ulleung-do. Mycobiology. 2014 Mar;42(1):79-81.

Apáti P, Houghton PJ, Kéry A. HPLC investigation of antioxidant components in Solidago herba. Acta Pharm Hung. 2004;74(4):223-31.

European Goldenrod // Herbal Medicines. – 4th edition. – 2013. – 928 p. Assessment report on Soidago virgaurea L. herba // European Medicines Agency. – 2008.

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society / Gupta K., Hooton T.M., Naber K.G. et al. // Clin. Infect. Dis. – 2011. – V. 52, № 5. – P. 103–120.

Chevalier M, Medioni E, Prêcheur I. Inhibition of Candida albicans yeasthyphal transition and biofilm formation by Solidago virgaurea water extracts. J Med Microbiol. 2012 Jul;61(Pt 7):1016-22.

Melzig M.F. New aspects for understanding the mechanism of the aquaretic effects of birch leaves and goldenrod // Zeitschrift fur Phytotherapie. – 2000. – V. 21, № 4. – P. 193–196.

Применение золотарника обыкновенного, хвоща полевого и лапчатки гусиной (Солидагорен) / А.В. Савустьяненко// Новости медиц. и фарм. – 2015. – № 6. – С. 12–17.

Wagener H.H. Zur Pharmakologie eines Solidago-Extrakt-haltigen Venenmittels // Arzneimittelforschung. – 1966. – V. 16. – P. 859–866.

Meyer B., Schneider W., Elstner E.F. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. – 1995. –V. 45, № 2. – P. 174–176.

Plohmann B., Bader G.T., Hiller K., Franz G. Immunomodulatory and antitumoral effects of triterpenoid saponins // Pharmazie. – 1997. – V. 12. – P. 953–957.

Plohmann B., Franz G., Bader G., Hiller K. Immunmodulatorische und antitumorale Aktivität von Tri-terpensaponinen aus Solidago virgaurea L. // Drogenreport. – 1999. – V. 12. – P. 29–30.

Schmitt M. Echte Goldrute normaliesiert die Reizblase. Effective und nebenwirkungsarme Behandlung abakterieller Cystiden // TW Urologie Nephrologie. – 1996. – V. 8. – P. 133–135.

Kruedener S. von, Schneider W., Elstner E.F. A combination of Populus tremula, Solidago virgaurea and Fraxinus excelsior as an anti-inflammatory and antirheumatic drug. A short review. Arzneimittelforschung. 1995 Feb;45(2):169-71.

Chodera A, Dabrowska K, Sloderbach A, Skrzypczak L, Budzianowski J. Effect of flavonoid fractions of Solidago virgaurea L on diuresis and levels of electrolytes. Acta Pol Pharm. 1991;48(5-6):35-7.

Apáti P., Szentmihályi K., Kristó S.T. et al. Herbal remedies of Solidago–correlation of phytochemical characteristics and antioxidative properties. J Pharm Biomed Anal. 2003 Aug 8;32(4-5):1045-53.

Wu B., Takahashi T, Kashiwagi T, Tebayashi S, Kim CS. New flavonoid glycosides from the leaves of Solidago altissima. Chem Pharm Bull (Tokyo). 2007 May;55(5):815-6.

Gross SC, Goodarzi G, Watabe M, Bandyopadhyay S, Pai SK, Watabe K. Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model. Nutr Cancer. 2002;43(1):76-81.

El-Tantawy W.H. Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity. J Physiol Biochem. 2014 Mar;70(1):33-42.

Marczyiński Z. Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances. Polim Med. 2009;39(4):51-60.

Berner-Strzelczyk A, Kołodziejska J, Piechota-Urbańska M, Zgoda MM. The evaluation of ketoprofen pharmaceutical availability in the presence of a dry extract from goldenrod (Solidago virgaurea L.) of synthetic polymer vehicles. Polim Med. 2009;39(4):39-44.

Starks CM, Williams RB, Goering MG, O’Neil-Johnson M, Norman VL, Hu JF, Garo E, Hough GW, Rice SM, Eldridge GR. Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea). Phytochemistry. 2010 Jan;71(1):104-9.

Nair R, Kalariya T, Chanda S. Antibacterial activity of some plant extracts used in folk medicine. J Herb Pharmacother. 2007;7(3-4):191-201.

Pagano E, Laudato M, Griffo M, Capasso R. Phytotherapy of benign prostatic hyperplasia. A minireview. Phytother Res. 2014 Jul;28(7):949-55.

Tomar PP, Nikhil K, Singh A, Selvakumar P, Roy P, Sharma AK. Characterization of anticancer, DNase and antifungal activity of pumpkin 2S albumin. Biochem Biophys Res Commun. 2014 Jun 13;448(4):349-54.

Medical lexicon: a dictionary of medical science: containing a concise explanation of the various subjects and terms of physiology, pathology, hygiene, therapeutics, pharmacology, obstetrics, medical jurisprudence, &c., with the French and other synonyms : notices of climate, and of celebrated mineral waters : formulae for various officinal, empirical, and dietetic preparations, etc . Philadelphia: Blanchard and Lea, 1855. Text 927, 32 p.

Лікарські рослини: Енциклопедичний довідник / Відп. ред. А.М. Гродзінський. – К.: Голов. ред. УРЕ, 1990. – 544 с.

Chrubasik S, Pollak S. Pain management with herbal antirheumatic drugs. WienMed Wochenschr. 2002;152(7-8):198-203.

Krylova SG, Zueva EP, Razina TG, Turetskova VF, Amosova EN. A dried aspenbark extract in the experimental therapy of gastric peptic ulcer. Eksp Klin-Farmakol. 2000 Mar-Apr;63(2):44-7.

Amosova E.N., Zueva E.P., Razina T.G. et al. The search for new antiulcer agents from plants in Siberia and the Far East. Eksp Klin Farmakol. 1998 Nov-Dec;61(6):31-5.

Gundermann K.J., Müller J. Phytodolor-effects and efficacy of a herbal medicine. Wien Med Wochenschr. 2007;157(13-14):343-7.

Информация для медицинских и фармацевтических работников для использования в профессиональной деятельности. Простамед: Р.С. МЗ Украины UA/6931/01/01 от 16.11.2012.

Горпинченко И.И., Гурженко Ю.Н. (2012) Применение препарата Простамед в комплексном лечении больных с экскреторно-токсическим бесплодием // Здоровье мужчины, № 1 (40). – С.141–148.

Гурженко Ю.Н., Аксенов П.В. (2012) Препарат Простамед в лечении больных доброкачественной гиперплазией предстательной железы // Інформаційне повідомлення з проблеми «Сексопатологія та андрологія», Протокол № 5 від 24.05.2012.

Горпинченко И.И., Гурженко Ю.Н., Спиридоненко В.В. Применение препарата Простамед в комплексном лечении больных хроническим простатитом, осложненным экскреторно-токсическим бесплодием. Материалы научно-практической конференции «Урология, андрология, нефрология-2014» 28-30.05.2014, Харьков, С. 86–93.